Meag Munich Ergo, Kapitalanlagegesellschaft Mbh / ABBV
Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s Abbvie Inc Position
Does Meag Munich Ergo, Kapitalanlagegesellschaft Mbh own Abbvie Inc (ABBV)? Yes — 162.6K shares worth $30M (+0.85% of its 13F portfolio) as of Q2 2025, down from 176.3K shares the prior filed quarter.
Position Value
$30M
Q2 2025
Shares
162.6K
% of Portfolio
+0.85%
Quarters Held
27
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 162.6K | $30M | +0.85% |
| Q1 2025 | 176.3K | $37M | +1.09% |
| Q4 2024 | 175.3K | $31M | +0.98% |
| Q3 2024 | 172.6K | $34M | +1.07% |
| Q2 2024 | 168.7K | $29M | +0.96% |
| Q1 2024 | 90.9K | $17M | +0.60% |
| Q4 2023 | 94.8K | $15M | +0.56% |
| Q3 2023 | 93.0K | $14M | +0.60% |
| Q2 2023 | 92.8K | $13M | +0.55% |
| Q1 2023 | 93.5K | $15M | +0.70% |
| Q4 2022 | 50.4K | $8M | +0.44% |
| Q3 2022 | 50.7K | $7M | +0.41% |
| Q2 2022 | 50.4K | $8M | +0.46% |
| Q1 2022 | 500 | $82,000 | +0.01% |
| Q4 2021 | 3.5K | $471,000 | +0.03% |
| Q3 2021 | 3.5K | $373,000 | +0.06% |
| Q2 2021 | 3.5K | $389,000 | +0.04% |
| Q1 2021 | 70.4K | $8M | +0.77% |
| Q4 2020 | 19.7K | $2M | +0.48% |
| Q3 2020 | 26.6K | $2M | +0.43% |
| Q2 2020 | 43.0K | $4M | +0.79% |
| Q1 2020 | 43.0K | $3M | +0.78% |
| Q4 2019 | 77.6K | $7M | +0.73% |
| Q3 2019 | 144.1K | $11M | +0.55% |
| Q2 2019 | 91.0K | $6M | +0.50% |
| Q1 2019 | 84.2K | $7M | +0.55% |
| Q4 2018 | 7.8K | $708,000 | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s full portfolio or all institutional holders of ABBV.